Study Of Factors Favoring The Onset Of Novo Atrial Fibrillation In The Immediate Aftermath Of Coronary Artery Bypass Surgery

January 22, 2014 updated by: Centre Hospitalier Universitaire Dijon

STUDY OF FACTORS FAVORING THE ONSET OF NOVO ATRIAL FIBRILLATION IN THE IMMEDIATE AFTERMATH OF CORONARY ARTERY BYPASS SURGERY

Before la surgery:

Transthoracic cardiac echography will be done systematically, to measure among other things the size of the left atrium.

During surgery:

Surgery under extracorporeal circulation: tissue samples will be harvested from the right atrium (one before clamping of the aorta (T0= pre-ischemia sample), immediately before declamping of the aorta (T1= post-ischemia sample).

Surgery without extracorporeal circulation: tissue samples from the right atrium before CABG (T0) and a second sample after CABG (T1).

In parallel with the harvesting of cardiac tissue, blood samples will be taken at different times (H0, H3, H24) to correlate tissue data with systemic data. These will be taken by the anesthetists.

After the surgery:

Holter ECG will be set up for 7 days of continuous recording. Each patient will fill in an observation notebook. The biological samples will be analysed immediately and the biological data obtained will be recorded in the observation notebook.

Study Overview

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dijon, France, 21079
        • CHU de Dijon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Coronary artery bypass graft with or without extracorporeal circulation

Description

Inclusion Criteria:

  • Patients who have provided written informed consent
  • Patients covered by the national health insurance scheme
  • Heart surgery (CABG) with and without extracorporeal circulation
  • Elective or deferred emergency surgery
  • Consecutive patients aged less than 80 years

Exclusion Criteria:

  • Patients less than 18, under guardianship
  • Patients over 18, under guardianship
  • Patients who do not understand the study data
  • Patients undergoing emergency surgery who therefore cannot be given or understand the explanations for the study (patients in shock, intubated patients with mechanical ventilation)
  • History of heart surgery
  • History of AF
  • Treatment with Cordarone.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients about to undergo heart surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Onset or a de novo episode of atrial fibrillation during the 7 days following heart surgery
Time Frame: 7 days post-surgery
7 days post-surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Markers of ischemia: circulating Troponin I before the surgery and at the end of the procedure
Time Frame: Baseline and at the end of surgery (15 minutes after unclamping when extracorporeal circulation)
Baseline and at the end of surgery (15 minutes after unclamping when extracorporeal circulation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

January 17, 2014

First Submitted That Met QC Criteria

January 22, 2014

First Posted (Estimate)

January 23, 2014

Study Record Updates

Last Update Posted (Estimate)

January 23, 2014

Last Update Submitted That Met QC Criteria

January 22, 2014

Last Verified

November 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • LAURENT PARI 2010

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Bypass Graft With or Without ECC

Clinical Trials on Blood samples

Subscribe